Evidence map›Paper›PMID 41445626›Full record

ArticlemedRxiv : the preprint server for health sciences2025

Reduced expression of N-methyl-D-aspartate receptor and calcium signaling genes in gray matter is associated with cognitive function in patients with breast cancer.

Shelli R Kesler, Oscar Y Franco-Rocha, Manuela Kogon, Sarah Braun, Leah Tolby, Ruth Nyagaka, Alexa De La Torre Schutz, Douglas W Blayney, Oxana Palesh

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Shelli R Kesler
Oscar Y Franco-Rocha
Manuela Kogon
Sarah Braun
Leah Tolby
Ruth Nyagaka
Alexa De La Torre Schutz
Douglas W Blayney
Oxana Palesh

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cognitive decline is common after cancer, but little is known regarding the etiology of this adverse effect, especially in terms of molecular mechanisms. This prospective study obtained brain imaging and cognitive testing from 50 newly diagnosed women with primary breast cancer prior to any cancer treatment and 53 female controls. Participants completed up to 7 assessments for a total time span of 9.7 +/- 0.92 years. Imaging transcriptomics was used to measure the expression of genes in the brain involved in N-methyl-D-aspartate (NMDA) and calcium-mediated neurotransmission.

Identifiers

PMID41445626
PMCPMC12723779

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.